Form 4: Pieris Pharmaceuticals Director Sells Shares
Sentiment:
Insider Transaction (Form 4)
George M Jenkins, a Director of Pieris Pharmaceuticals, Inc., sold 27,500 shares of common stock on October 12, 2026.
Summary
- Open-market sale: disposed of 5,095 Common Stock at $132.62 ($675,681) on October 12, 2026; holds 155,021 after (Direct).
- Open-market sale: disposed of 2,458 Common Stock at $133.25 ($327,524) on October 12, 2026; holds 152,563 after (Direct).
- Open-market sale: disposed of 3,335 Common Stock at $134.21 ($447,586) on October 12, 2026; holds 149,228 after (Direct).
- Open-market sale: disposed of 1,447 Common Stock at $135.50 ($196,064) on October 12, 2026; holds 147,781 after (Direct).
- Open-market sale: disposed of 817 Common Stock at $136.44 ($111,475) on October 12, 2026; holds 146,964 after (Direct).
- Open-market sale: disposed of 2,004 Common Stock at $128.52 ($257,555) on October 13, 2026; holds 144,960 after (Direct).
- Open-market sale: disposed of 1,644 Common Stock at $129.23 ($212,455) on October 13, 2026; holds 143,316 after (Direct).
- Open-market sale: disposed of 990 Common Stock at $130.48 ($129,175) on October 13, 2026; holds 142,326 after (Direct).
- Open-market sale: disposed of 1,035 Common Stock at $131.49 ($136,092) on October 13, 2026; holds 141,291 after (Direct).
- Open-market sale: disposed of 579 Common Stock at $132.40 ($76,662) on October 13, 2026; holds 140,712 after (Direct).
- Open-market sale: disposed of 922 Common Stock at $133.72 ($123,292) on October 13, 2026; holds 139,790 after (Direct).
- Open-market sale: disposed of 476 Common Stock at $121.14 ($57,663) on October 14, 2026; holds 139,314 after (Direct).
- Open-market sale: disposed of 2,072 Common Stock at $122.62 ($254,058) on October 14, 2026; holds 137,242 after (Direct).
- Open-market sale: disposed of 2,604 Common Stock at $123.29 ($321,046) on October 14, 2026; holds 134,638 after (Direct).
- Open-market sale: disposed of 920 Common Stock at $124.37 ($114,416) on October 14, 2026; holds 133,718 after (Direct).
- Open-market sale: disposed of 597 Common Stock at $125.33 ($74,820) on October 14, 2026; holds 133,121 after (Direct).
- Open-market sale: disposed of 505 Common Stock at $126.55 ($63,910) on October 14, 2026; holds 132,616 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,579,476 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
George M Jenkins — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-12 | Open-market sale | Common Stock | 5,095 | $133 | $675.7K | 155,021 |
| 2026-10-12 | Open-market sale | Common Stock | 2,458 | $133 | $327.5K | 152,563 |
| 2026-10-12 | Open-market sale | Common Stock | 3,335 | $134 | $447.6K | 149,228 |
| 2026-10-12 | Open-market sale | Common Stock | 1,447 | $135 | $196.1K | 147,781 |
| 2026-10-12 | Open-market sale | Common Stock | 817 | $136 | $111.5K | 146,964 |
| 2026-10-13 | Open-market sale | Common Stock | 2,004 | $129 | $257.6K | 144,960 |
| 2026-10-13 | Open-market sale | Common Stock | 1,644 | $129 | $212.5K | 143,316 |
| 2026-10-13 | Open-market sale | Common Stock | 990 | $130 | $129.2K | 142,326 |
| 2026-10-13 | Open-market sale | Common Stock | 1,035 | $131 | $136.1K | 141,291 |
| 2026-10-13 | Open-market sale | Common Stock | 579 | $132 | $76.7K | 140,712 |
| 2026-10-13 | Open-market sale | Common Stock | 922 | $134 | $123.3K | 139,790 |
| 2026-10-14 | Open-market sale | Common Stock | 476 | $121 | $57.7K | 139,314 |
| 2026-10-14 | Open-market sale | Common Stock | 2,072 | $123 | $254.1K | 137,242 |
| 2026-10-14 | Open-market sale | Common Stock | 2,604 | $123 | $321.0K | 134,638 |
| 2026-10-14 | Open-market sale | Common Stock | 920 | $124 | $114.4K | 133,718 |
| 2026-10-14 | Open-market sale | Common Stock | 597 | $125 | $74.8K | 133,121 |
| 2026-10-14 | Open-market sale | Common Stock | 505 | $127 | $63.9K | 132,616 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-12 | Open-market sale (5,095 shares) |
| 2026-10-12 | Open-market sale (2,458 shares) |
| 2026-10-12 | Open-market sale (3,335 shares) |
| 2026-10-12 | Open-market sale (1,447 shares) |
| 2026-10-12 | Open-market sale (817 shares) |
| 2026-10-13 | Open-market sale (2,004 shares) |
| 2026-10-13 | Open-market sale (1,644 shares) |
| 2026-10-13 | Open-market sale (990 shares) |
| 2026-10-13 | Open-market sale (1,035 shares) |
| 2026-10-13 | Open-market sale (579 shares) |
| 2026-10-13 | Open-market sale (922 shares) |
| 2026-10-14 | Open-market sale (476 shares) |
| 2026-10-14 | Open-market sale (2,072 shares) |
| 2026-10-14 | Open-market sale (2,604 shares) |
| 2026-10-14 | Open-market sale (920 shares) |
| 2026-10-14 | Open-market sale (597 shares) |
| 2026-10-14 | Open-market sale (505 shares) |
Keywords
insider transaction, Form 4, PVLA, PALVELLA THERAPEUTICS, INC., bearish, George M Jenkins
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.